Pegylated liposomal doxorubicin augments the efficacy of engineered human T cells expressing a p53-specific T cell receptor against ovarian cancer

被引：1
|
作者：
Liao, J. [1 ]
Poussin, M. [2 ]
Hasegawa, K. [3 ]
Song, D. [2 ]
Powell, D. [2 ]
Coukos, G. [2 ]
机构：
[1] Univ Washington, Seattle, WA 98195 USA
[2] Univ Penn, Philadelphia, PA 19104 USA
[3] Saitama Med Univ, Saitama, Japan
来源：
GYNECOLOGIC ONCOLOGY | 2012年 / 125卷
关键词：
D O I：
10.1016/j.ygyno.2011.12.106
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
105
引用
收藏
页码：S45 / S45
页数：1
相关论文
共 50 条
  • [1] Wildtype p53-specific Antibody and T-Cell Responses in Cancer Patients
    Pedersen, Anders Elm
    Stryhn, Anette
    Justesen, Sune
    Harndahl, Mikkel
    Rasmussen, Susanne
    Donskov, Frede
    Claesson, Mogens H.
    Pedersen, Johannes W.
    Wandall, Hans H.
    Svane, Inge Marie
    Buus, Soren
    JOURNAL OF IMMUNOTHERAPY, 2011, 34 (09) : 629 - 640
  • [2] P53-specific T-cell responses in patients with malignant and benign ovarian tumors
    Lambeck, A.
    Hoogeboom, B. -N.
    Leffers, N.
    van der Burg, S.
    Offringa, R.
    Hamming, I.
    Klip, H.
    ten Hoor, K.
    Esajas, M.
    van Oven, M.
    Drijfhout, J. Wouter
    Platteel, I.
    Melief, C.
    Hollema, H.
    van der Zee, A.
    Daemen, T.
    Nijman, H.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2007, 56 (03) : 408 - 408
  • [3] P53-specific T cell responses in patients with malignant and benign ovarian tumors: Implications for p53 based immunotherapy
    Lambeck, Annechien
    Leffers, Ninke
    Hoogeboom, Baukje-Nynke
    Sluiter, Wim
    Hamming, Ineke
    Klip, Harry
    ten Hoor, Klaske
    Esajas, Martha
    van Oven, Magda
    Drijfhout, Jan-Wouter
    Platteel, Inge
    Offringa, Rienk
    Hollema, Harry
    Melief, Kees
    van der Burg, Sjoerd
    van der Zee, Ate
    Daemen, Toos
    Nijman, Hans
    INTERNATIONAL JOURNAL OF CANCER, 2007, 121 (03) : 606 - 614
  • [4] Induction of Neoantigen-Specific Cytotoxic T Cells and Construction of T-cell Receptor-Engineered T Cells for Ovarian Cancer
    Matsuda, Tatsuo
    Leisegang, Matthias
    Park, Jae-Hyun
    Ren, Lili
    Kato, Taigo
    Ikeda, Yuji
    Harada, Makiko
    Kiyotani, Kazuma
    Lengyel, Ernst
    Fleming, Gini F.
    Nakamura, Yusuke
    CLINICAL CANCER RESEARCH, 2018, 24 (21) : 5357 - 5367
  • [5] Family History of Cancer Rather Than p53 Status Predicts Efficacy of Pegylated Liposomal Doxorubicin and Oxaliplatin in Relapsed Ovarian Cancer
    Nicoletto, Maria Ornella
    Bertorelle, Roberta
    Borgato, Lucia
    De Salvo, Gian Luca
    Artioli, Grazia
    Lombardi, Giuseppe
    Zustovich, Fable
    Marcato, Raffella
    Parenti, Anna
    Montagna, Marco
    Donach, Martin E.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2009, 19 (06) : 1022 - 1028
  • [6] Antitumor efficacy of wild-type p53-specific CD4+ T-helper cells
    Zwaveling, S
    Vierboom, MPM
    Mota, SCF
    Hendriks, JA
    Ooms, ME
    Sutmuller, RPM
    Franken, KLMC
    Nijman, HW
    Ossendorp, F
    van der Burg, SH
    Offringa, R
    Melief, CJM
    CANCER RESEARCH, 2002, 62 (21) : 6187 - 6193
  • [7] Long lasting p53-specific T cell memory responses in the absence of anti-p53 antibodies in patients with resected primary colorectal cancer
    van der Burg, SH
    de Cock, K
    Menon, AG
    Franken, KLMC
    Palmen, M
    Redeker, A
    Drijfhout, JW
    Kuppen, PJK
    van de Velde, CJH
    Erdile, L
    Tollenaar, RAEM
    Melief, CJM
    Offringa, R
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2001, 31 (01) : 146 - 155
  • [8] CYTOTOXIC EFFECTS OF ALPHA FETOPROTEIN-SPECIFIC T CELL RECEPTOR ENGINEERED T CELLS AGAINST HEPATOCELLULAR CARCINOMA
    Mizukoshi, Eishiro
    Nakagawa, Hidetoshi
    Yamashita, Tatsuya
    Arai, Kuniaki
    Iida, Noriho
    Terashima, Takeshi
    Kaneko, Shuichi
    HEPATOLOGY, 2019, 70 : 207A - 207A
  • [9] T cell receptor-engineered T cells targeting a human endogenous retrovirus in kidney cancer.
    Barisic, Stefan
    Brahmbhatt, Elizabeth M.
    Cherkasova, Elena
    Nadal, Rosa
    Savani, Ujjawal
    Pierre, Stephanie
    Chen, Long
    Spear, Timothy T.
    Scurti, Gina M.
    Zeng, Gang
    Parry, Gordon
    Stroncek, David F.
    Highfill, Steven L.
    Dalheim, Annika V.
    Reger, Robert N.
    Nishimura, Michael I.
    Childs, Richard W.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [10] Development of Engineered T Cells Expressing a Chimeric CD16-CD3ζ Receptor to Improve the Clinical Efficacy of Mogamulizumab Therapy Against Adult T-Cell Leukemia
    Tanaka, Hiroki
    Fujiwara, Hiroshi
    Ochi, Fumihiro
    Tanimoto, Kazushi
    Casey, Nicholas
    Okamoto, Sachiko
    Mineno, Junichi
    Kuzushima, Kiyotaka
    Shiku, Hiroshi
    Sugiyama, Takashi
    Barrett, A. John
    Yasukawa, Masaki
    CLINICAL CANCER RESEARCH, 2016, 22 (17) : 4405 - 4416
12345